
US Biomanufacturing Reshoring Policy Extends Relevance to Agrochemical Supply Chain Security
The BIOSECURE Act and associated federal biomanufacturing investment cited in the Again-Genomatica

prodchem
Aug 17, 2026
Bio-based materials are becoming an increasingly important source of differentiation across the chemical industry.
For years, chemical companies competed primarily through cost, scale, product performance and production efficiency. That model remains important, particularly in base chemicals, but a new competitive factor is becoming more visible: the ability to offer materials derived partly or entirely from renewable biological resources.
The shift is especially relevant in Europe, where policymakers are increasingly linking bio-based production with industrial competitiveness, strategic autonomy and reduced dependence on fossil resources. The European Commission identifies bio-based plastics and polymers, bio-based chemicals, fibres, construction products, fertilizers and crop-protection products among the priority markets for the region's bioeconomy.
For chemical producers, this means bio-based materials are moving beyond a sustainability story.
They are becoming a potential commercial differentiator.
Traditional chemical production relies heavily on fossil-derived feedstocks.
Bio-based production can instead use renewable resources such as:
Agricultural residues
Forestry by-products
Plant oils
Sugars
Starch
Cellulose
Lignin
Food-processing residues
Microalgae
These feedstocks can be converted into chemicals, polymers, coatings, fibers and other industrial materials.
The Circular Bio-based Europe Joint Undertaking has highlighted applications ranging from packaging and automotive components to cosmetics, fertilizers and household products.
This creates an opportunity for chemical companies to compete on something beyond price.

Historically, sustainability was often treated as a corporate responsibility issue.
That is changing.
Customers increasingly want to know:
Where did the feedstock come from?
How much fossil carbon does the product contain?
Can the material be recycled?
Does it reduce greenhouse-gas emissions?
Is the feedstock renewable?
Can the material meet regulatory requirements?
Does it maintain the same technical performance?
As these questions become part of procurement decisions, the sustainability characteristics of a chemical can influence purchasing.
That effectively turns environmental performance into a product attribute.
There is an important distinction.
A bio-based material is not automatically:
Lower carbon
Cheaper
More recyclable
More durable
More sustainable
The overall environmental performance depends on the feedstock, production process, land use, energy source, transportation and end-of-life pathway.
This is why customers are increasingly interested in measurable lifecycle performance rather than simply a "bio-based" label.
The strongest products will therefore be those that combine renewable feedstocks with strong technical and environmental performance.
This is where bio-based materials become particularly interesting for investors.
Commodity chemicals are usually differentiated very little.
If two suppliers offer essentially identical products, price becomes a major purchasing factor.
Bio-based materials can create differentiation through:
Feedstock origin
Lower fossil content
Carbon footprint
Renewable-content certification
Traceability
Product formulation
Technical performance
Sustainability credentials
That can make customer relationships more valuable and potentially reduce direct price competition.
Bio-based materials fit naturally into the specialty-chemical business model.
Specialty producers already compete through:
Performance
Formulation
Technical expertise
Customer qualification
Application development
Regulatory knowledge
Adding renewable feedstocks gives them another layer of differentiation.
That is why bio-based materials may become especially attractive in higher-value applications rather than only in large-volume commodities.
Europe's chemical industry is under pressure from high energy costs, global competition and declining competitiveness in some base-chemical segments.
Bio-based materials offer one potential path toward a more differentiated industrial model.
The European Commission estimates the broader European bioeconomy already represented up to €863 billion in value added and 17.1 million jobs in 2023.
The policy direction is also becoming clearer.
The Council of the EU backed a bioeconomy strategy focused on moving renewable biological resources into industrial applications while strengthening competitiveness, sustainability and strategic autonomy.
Despite the opportunity, bio-based chemicals remain a relatively small part of the overall chemical industry.
A July 2026 report from the Bio-based Industries Consortium estimates that only around 8% of Europe's €655 billion chemicals industry is currently bio-based.
That is both a limitation and an opportunity.
The technology has not yet displaced conventional chemical production at scale.
But the relatively low penetration means there is considerable room for expansion if costs, infrastructure and customer demand improve.
The biggest obstacle is economics.
Fossil-based chemical production benefits from:
Massive existing infrastructure
Established feedstock markets
Large-scale plants
Mature logistics
Integrated production networks
Decades of process optimization
Bio-based producers often face:
Higher feedstock costs
Smaller production scale
Feedstock variability
Limited infrastructure
More expensive processing
Qualification costs
A sustainable product that costs substantially more than its conventional equivalent may struggle to achieve mass adoption without additional customer value or policy support.
Many bio-based technologies work in laboratories or demonstration facilities.
The difficult part is commercial scale.
Europe has identified financing gaps at precisely this point in the development cycle. The European Commission describes two major "valleys of death" between demonstration and commercialization, particularly around TRL 5–7 and TRL 7–9.
This is important because chemical manufacturing is capital-intensive.
A successful laboratory process still needs:
Technology → Demonstration → Pilot → Commercial plant → Reliable supply
The companies that successfully navigate that sequence could establish significant competitive advantages.
The policy push is increasingly supported by capital.
The Circular Bio-based Europe Joint Undertaking launched a €170.7 million 2026 funding call covering 13 topics across biorefineries, residual biomass, bio-based chemicals, polymers, additives and circular packaging.
In May 2026, CBE JU also announced 24 new projects receiving €172 million to scale competitive circular bio-based industries across Europe.
These investments are designed to move technologies closer to industrial deployment.
One of the biggest problems for new bio-based plants is demand certainty.
Building a new facility requires large upfront investment.
Investors therefore want confidence that customers will actually purchase the resulting materials.
The European Commission's proposed Bio-based Europe Alliance is intended to address exactly this issue, with a target of securing €10 billion of purchase commitments for bio-based materials and products by 2030.
That could help turn sustainability commitments into actual industrial demand.
Procurement teams are increasingly important to the commercialization process.
If large manufacturers commit to buying renewable-content materials, producers gain the confidence needed to build new capacity.
That creates a potentially powerful cycle:
Customer commitment → Investment → Capacity → Lower unit costs → Wider adoption
Without that demand signal, many bio-based technologies can remain stuck at pilot scale.
Packaging is one of the most obvious applications.
Europe is tightening requirements around packaging waste, recyclability and material design.
New EU packaging rules are aimed at making packaging recyclable at scale, increasing reuse and reducing waste across the bloc.
This creates opportunities for materials that can provide:
Renewable feedstocks
Recyclability
Lower fossil dependence
Improved material efficiency
Better end-of-life performance
Bio-based polymers and coatings can therefore become part of broader packaging redesign.

Featured Product
Automotive manufacturers are also exploring renewable and lower-carbon materials.
Potential applications include:
Interior components
Lightweight composites
Coatings
Adhesives
Engineering polymers
Foams
The key requirement is performance.
Automotive customers cannot sacrifice durability, safety or reliability simply to improve sustainability metrics.
That creates an interesting opportunity for chemical companies that can deliver both performance and lower environmental impact.
Construction is another large potential market.
Bio-based materials can be incorporated into:
Insulation
Resins
Coatings
Adhesives
Composite materials
Structural products
The European Commission specifically identifies bio-based construction products as one of the lead markets for the region's bioeconomy.
As building regulations increasingly emphasize lifecycle emissions and resource efficiency, this segment could become increasingly attractive.
Bio-based chemistry is not limited to plastics.
Europe's 2026 bioeconomy funding priorities include safe-and-sustainable-by-design bio-based alternatives for fertilizers and crop-protection products.
That creates opportunities for chemical companies developing:
Biological inputs
Bio-based adjuvants
Renewable intermediates
Sustainable formulations
Biodegradable materials
Agriculture could therefore become another important market for bio-based specialty chemistry.
Some of the most interesting opportunities are not finished products.
They are platform chemicals that can replace petrochemical intermediates across multiple applications.
Examples include:
Glycerol
Lactic acid
Succinic acid
Fumaric acid
Malic acid
1,3-propanediol
FDCA
Isobutanol
Market research indicates growing interest in these materials as potential replacements for petrochemical intermediates used in polymers, coatings, pharmaceuticals and other applications.
That makes platform chemistry particularly interesting from an investment perspective.
Traditional chemical complexes are built around fossil feedstocks.
The emerging alternative is the biorefinery.
Instead of converting crude oil or natural gas into multiple chemical products, a biorefinery can process biomass into:
Feedstock → Platform chemicals → Polymers / materials / fuels / ingredients
The European Commission has identified biorefineries as a priority technology market for the European bioeconomy.
CBE JU says its projects have already supported the development of 23 first-of-their-kind biorefineries across Europe.
Bio-based chemistry creates a different supply-chain challenge.
Instead of depending primarily on oil and gas, producers may depend on:
Agricultural residues
Forestry waste
Sugar
Oils
Starch
Biomass
Food-processing by-products
That means companies need reliable feedstock networks.
The European Commission's 2026 program specifically highlights the importance of optimizing biomass supply chains, including sourcing, storage and transportation of woody residues.
So the new competitive advantage may not simply be the chemistry.
It may be control over sustainable feedstock supply.
Bio-based supply chains can also be geographically different from conventional chemical supply chains.
A producer may need to move biomass from rural areas to a centralized processing facility.
That creates requirements for:
Collection networks
Storage
Transportation
Feedstock aggregation
Seasonal inventory management
The logistics model therefore becomes part of the economics of the final chemical.
Customers increasingly want evidence that renewable feedstocks are genuinely renewable.
This makes traceability increasingly important.
Producers may need to demonstrate:
Feedstock origin
Renewable content
Chain of custody
Carbon footprint
Processing methods
Environmental performance
Companies with strong certification and documentation systems could therefore gain an advantage over less transparent competitors.
Regulation is another important differentiator.
When governments establish requirements around:
Renewable content
Carbon emissions
Packaging
Recyclability
Sustainable procurement
the economics of bio-based products can improve.
This is particularly important because many bio-based materials cannot yet compete purely on cost.
Policy can help close that gap by rewarding attributes that conventional products do not provide.

The opposite is also true.
If regulations change, companies may find that investments expected to receive premium pricing no longer qualify.
Therefore, investors should distinguish between:
Technology-driven demand
and
Policy-driven demand
The strongest businesses ideally benefit from both.
Another misconception is that biotechnology automatically makes chemical production cheaper.
It does not.
Large fermentation systems, purification equipment and biorefineries can require substantial capital.
The real advantage comes when companies can combine:
Efficient biological conversion
Cheap feedstocks
High plant utilization
Strong product pricing
Multiple downstream applications
That is when the economics become compelling.
The future winners are unlikely to sell sustainability alone.
They will sell a better product.
That could mean:
Better performance
Lower carbon footprint
Renewable content
Improved recyclability
Lower toxicity
Better regulatory positioning
The sustainability benefit becomes a competitive multiplier, rather than the entire value proposition.
Bio-based materials may become one of the next major sources of specialty-chemical differentiation.
Traditional specialty chemicals compete through performance.
The next generation may compete through:
Performance + Sustainability + Traceability
That combination could create stronger customer relationships and potentially higher margins.
Investors should look beyond headline announcements.
The important questions are:
Laboratory success does not guarantee commercial success.
A sustainable feedstock that is too expensive can destroy margins.
Offtake agreements reduce commercialization risk.
Renewable content alone may not justify a premium.
Capital-intensive sustainability projects still need economic returns.
Patents, feedstock access and customer qualification can create barriers to entry.
Procurement teams should increasingly evaluate bio-based materials alongside conventional alternatives.
Key questions include:
What percentage of the product is bio-based?
Is the feedstock traceable?
What is the lifecycle carbon footprint?
Does performance match the conventional material?
Is supply available at commercial scale?
How stable is pricing?
Are certifications available?
Can the supplier guarantee long-term availability?
These questions can prevent sustainability claims from being treated as a substitute for supply-chain reliability.
Europe has no shortage of bio-based research.
The bigger challenge is commercial deployment.
BIC's July 2026 analysis concluded that Europe's bio-based sector is being held back less by a lack of technology than by insufficient market and regulatory signals that stimulate demand.
That means the next phase of competition may be about commercialization rather than invention.
The companies that can move from:
Pilot plant → Commercial capacity → Customer adoption
could establish valuable positions before the market becomes crowded.
Bio-based materials are unlikely to replace conventional chemicals across the entire industry.
The economics simply do not support that outcome today.
But they do not need to.
The more important opportunity is selective substitution in markets where customers are willing to pay for a combination of performance, sustainability, traceability and regulatory advantages.
Europe is actively trying to create those markets. The European Commission's bioeconomy program targets new manufacturing capacity and aims to mobilize €10 billion of bio-based product offtake commitments by 2030, while CBE JU is directing hundreds of millions of euros toward commercialization and scale-up.
For chemical companies, the strategic lesson is clear:
Bio-based materials are becoming more than an ESG initiative. They are becoming another way to differentiate a chemical product in an increasingly commoditized market.
The companies that succeed will not simply be the ones with the greenest story.
They will be the ones that can make renewable materials competitive, scalable, traceable and technically superior enough for customers to switch.
Bio-based materials are emerging as a new source of differentiation in chemicals.
Europe is actively supporting bio-based chemicals, polymers, construction materials and other applications.
Only around 8% of Europe's chemicals industry is currently bio-based, leaving significant room for expansion.
Cost and scale remain major barriers to adoption.
Offtake agreements and government support can help close the commercialization gap.
Biorefineries and platform chemicals could become important components of future chemical supply chains.
Feedstock security, logistics and traceability will become increasingly important competitive factors.
Packaging, automotive, construction, agriculture and specialty formulations offer important potential growth markets.
The strongest bio-based products will combine sustainability with technical performance rather than relying on environmental claims alone.
Bio-based chemistry could become one of the next major differentiators separating high-value specialty chemical businesses from more commoditized competitors.
Found this useful?
Continue Reading

The BIOSECURE Act and associated federal biomanufacturing investment cited in the Again-Genomatica

Genomatica's extensive experimental and scale-up data, spanning nearly 30 years of fermentation process development

The expected August propylene price rise in Asia has modest downstream relevance to polypropylene-based agrochemical packaging costs